In Vitro and In Vivo Activity of a Novel Antifungal Small Molecule against Candida Infections

Candida is the most common fungal pathogen of humans worldwide and has become a major clinical problem because of the growing number of immunocompromised patients, who are susceptible to infection. Moreover, the number of available antifungals is limited, and antifungal-resistant Candida strains are...

Descripción completa

Detalles Bibliográficos
Autores principales: Wong, Sarah Sze Wah, Kao, Richard Yi Tsun, Yuen, Kwok Yong, Wang, Yu, Yang, Dan, Samaranayake, Lakshman Perera, Seneviratne, Chaminda Jayampath
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3899067/
https://www.ncbi.nlm.nih.gov/pubmed/24465737
http://dx.doi.org/10.1371/journal.pone.0085836

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3899067/
https://www.ncbi.nlm.nih.gov/pubmed/24465737
http://dx.doi.org/10.1371/journal.pone.0085836

Ejemplares similares